| Neil A Braunstein, MD | |
|
4750 W Oakey Blvd Ste 3a, Las Vegas, NV 89102 | |
| (702) 877-5199 | |
| Not Available |
| Full Name | Neil A Braunstein |
|---|---|
| Gender | Male |
| Speciality | Rheumatology |
| Experience | 27 Years |
| Location | 4750 W Oakey Blvd Ste 3a, Las Vegas, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1265434716 | NPI | - | NPPES |
| 100509938 | Medicaid | NV | |
| P00857368 | Other | NV | RR MEDICAID ID # |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RR0500X | Internal Medicine - Rheumatology | MD070237L (Pennsylvania) | Secondary |
| 207RR0500X | Internal Medicine - Rheumatology | 11851 (Nevada) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Optum Medical Group Ii Rhodes P C | 4981687779 | 318 |
News Archive
Kaiser Health News staff writer Christopher Weaver reports: "New consumer-controlled health insurance plans could get seed money from the government to increase competition - and maybe cut prices - under new rules announced Monday by the Department of Health and Human Services".
A new report by researchers at the University of Melbourne and published on the preprint server bioRxiv in September 2020 reports on the use of a two-protein two-dose vaccine regimen and its immunogenicity in two animal models.
In the last 10 years, the U.S. military has experienced an unprecedented increase in suicides among personnel. While many researchers have largely focused on risk factors among individual soldiers, in a new study, researchers contend that the increase in suicide may also indicate increased vulnerability among more recent generations of young adults. Evidence supporting this perspective is out today in Armed Services and Society (a SAGE journal).
VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies, today presented results from a study of VRX1116 at HIV DART 2010 in Los Cabos, Mexico, showing that vaccinated monkeys challenged with highly pathogenic simian immunodeficiency virus achieve sustained viral load reduction, preservation of the immune system and increased survival compared to controls.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long-term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that the last patient in the Phase III clinical trial being conducted by its collaborative partner, Alimera Sciences, for a new treatment for diabetic macular edema (DME) has completed the two-year follow up visit.
› Verified 4 days ago
| Entity Name | Southwest Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659346005 PECOS PAC ID: 6103730544 Enrollment ID: O20031118001102 |
News Archive
Kaiser Health News staff writer Christopher Weaver reports: "New consumer-controlled health insurance plans could get seed money from the government to increase competition - and maybe cut prices - under new rules announced Monday by the Department of Health and Human Services".
A new report by researchers at the University of Melbourne and published on the preprint server bioRxiv in September 2020 reports on the use of a two-protein two-dose vaccine regimen and its immunogenicity in two animal models.
In the last 10 years, the U.S. military has experienced an unprecedented increase in suicides among personnel. While many researchers have largely focused on risk factors among individual soldiers, in a new study, researchers contend that the increase in suicide may also indicate increased vulnerability among more recent generations of young adults. Evidence supporting this perspective is out today in Armed Services and Society (a SAGE journal).
VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies, today presented results from a study of VRX1116 at HIV DART 2010 in Los Cabos, Mexico, showing that vaccinated monkeys challenged with highly pathogenic simian immunodeficiency virus achieve sustained viral load reduction, preservation of the immune system and increased survival compared to controls.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long-term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that the last patient in the Phase III clinical trial being conducted by its collaborative partner, Alimera Sciences, for a new treatment for diabetic macular edema (DME) has completed the two-year follow up visit.
› Verified 4 days ago
| Entity Name | Optum Medical Group Ii Rhodes P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1770556037 PECOS PAC ID: 4981687779 Enrollment ID: O20040611000770 |
News Archive
Kaiser Health News staff writer Christopher Weaver reports: "New consumer-controlled health insurance plans could get seed money from the government to increase competition - and maybe cut prices - under new rules announced Monday by the Department of Health and Human Services".
A new report by researchers at the University of Melbourne and published on the preprint server bioRxiv in September 2020 reports on the use of a two-protein two-dose vaccine regimen and its immunogenicity in two animal models.
In the last 10 years, the U.S. military has experienced an unprecedented increase in suicides among personnel. While many researchers have largely focused on risk factors among individual soldiers, in a new study, researchers contend that the increase in suicide may also indicate increased vulnerability among more recent generations of young adults. Evidence supporting this perspective is out today in Armed Services and Society (a SAGE journal).
VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies, today presented results from a study of VRX1116 at HIV DART 2010 in Los Cabos, Mexico, showing that vaccinated monkeys challenged with highly pathogenic simian immunodeficiency virus achieve sustained viral load reduction, preservation of the immune system and increased survival compared to controls.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long-term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that the last patient in the Phase III clinical trial being conducted by its collaborative partner, Alimera Sciences, for a new treatment for diabetic macular edema (DME) has completed the two-year follow up visit.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Neil A Braunstein, MD Po Box 35380, Las Vegas, NV 89133-5380 Ph: (702) 877-5199 | Neil A Braunstein, MD 4750 W Oakey Blvd Ste 3a, Las Vegas, NV 89102 Ph: (702) 877-5199 |
News Archive
Kaiser Health News staff writer Christopher Weaver reports: "New consumer-controlled health insurance plans could get seed money from the government to increase competition - and maybe cut prices - under new rules announced Monday by the Department of Health and Human Services".
A new report by researchers at the University of Melbourne and published on the preprint server bioRxiv in September 2020 reports on the use of a two-protein two-dose vaccine regimen and its immunogenicity in two animal models.
In the last 10 years, the U.S. military has experienced an unprecedented increase in suicides among personnel. While many researchers have largely focused on risk factors among individual soldiers, in a new study, researchers contend that the increase in suicide may also indicate increased vulnerability among more recent generations of young adults. Evidence supporting this perspective is out today in Armed Services and Society (a SAGE journal).
VIRxSYS Corporation, a privately held company developing vaccines and RNA therapies, today presented results from a study of VRX1116 at HIV DART 2010 in Los Cabos, Mexico, showing that vaccinated monkeys challenged with highly pathogenic simian immunodeficiency virus achieve sustained viral load reduction, preservation of the immune system and increased survival compared to controls.
pSivida Corp., a leading drug delivery company that has developed two of the only three products approved by the FDA for the long-term, sustained release delivery of drug to treat chronic back of the eye disease, today announced that the last patient in the Phase III clinical trial being conducted by its collaborative partner, Alimera Sciences, for a new treatment for diabetic macular edema (DME) has completed the two-year follow up visit.
› Verified 4 days ago
Dr. Arshi A. Quadeer, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 2545 S Bruce St Ste 200, Las Vegas, NV 89169 Phone: 702-732-2438 Fax: 702-737-5043 | |
Cherie Lin, D.O. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 3006 S Maryland Pkwy, Suite 400, Las Vegas, NV 89109 Phone: 702-369-5582 Fax: 702-369-1533 | |
Michael M Lee, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-921-6823 Fax: 702-549-5240 | |
Henry Palangdao Igid, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 653 N Town Center Dr Ste 402, Las Vegas, NV 89144 Phone: 702-243-7200 Fax: 702-243-7235 | |
Ian Adrian Fanoga Frani, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 1800 W Charleston Blvd, Las Vegas, NV 89102 Phone: 702-383-2000 Fax: 702-383-3875 | |
Sein Tun, DO Rheumatology Medicare: Medicare Enrolled Practice Location: 620 Shadow Ln, Las Vegas, NV 89106 Phone: 702-388-4000 | |
Berge Jack Dadourian, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 400 S Rampart Blvd, Suite 240, Las Vegas, NV 89145 Phone: 702-906-1100 Fax: 702-906-1110 |